Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
1992-6-26
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0890-9091
|
pubmed:issnType |
Print
|
pubmed:volume |
5
|
pubmed:owner |
NLM
|
pubmed:pagination |
59
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1840024-Acquired Immunodeficiency Syndrome,
pubmed-meshheading:1840024-Administration, Oral,
pubmed-meshheading:1840024-Atovaquone,
pubmed-meshheading:1840024-Drugs, Investigational,
pubmed-meshheading:1840024-Humans,
pubmed-meshheading:1840024-Naphthoquinones,
pubmed-meshheading:1840024-Pneumonia, Pneumocystis
|
pubmed:year |
1991
|
pubmed:articleTitle |
FDA authorizes wider use of new oral medication for AIDS.
|
pubmed:publicationType |
News
|